Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Sewickley › NPI 1588770416
Hospital

Valley Medical Facilities INC

Valley Medical Facilities INC was paid $4.22M by Medicaid between Jan 2018 and Dec 2024, across 173 billing codes. Its largest line is 99284, emergency room visit (serious) — 34% of everything it billed.

33Billing provider infoVALLEY MEDICAL FACILITIES INC
SEWICKLEY, PA 15143
33aNPI1588770416assigned 08/22/2006
28Total paid$4.22M
24GClaims137,432
24DCodes billed173
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Pennsylvania

Rank by total paid#69 of 154
Median peer was paid$2.82M
This provider vs. median1.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018223$11K
2019306$8K
202014,218$346K
202180,292$2.11M
202217,453$645K
202317,236$771K
2024incomplete7,704$331K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 34% 13,420 12,004 $1.42M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 16% 9,017 8,033 $661K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 9.9% 3,202 2,924 $420K
G0378 Hospital observation service, per hour 4.7% 754 347 $199K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.3% 785 763 $141K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 2.7% 1,308 1,241 $114K
80053 Comprehensive metabolic panel 2.5% 9,626 9,113 $104K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.3% 3,516 3,357 $95K
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 1.6% 1,757 525 $68K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1.3% 573 570 $56K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.3% 9,954 9,423 $55K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.2% 1,510 1,479 $50K
161 more codes
71275 Computed tomographic angiography, chest, with contrast material 1.1% 241 $48K
70450 Computed tomography, head or brain; without contrast material <1% 712 $40K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 945 $37K
71046 Radiologic examination, chest; 2 views <1% 2,184 $32K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 377 $31K
96375 Therapeutic injection; each additional sequential IV push <1% 1,600 $28K
80050 General health panel <1% 526 $27K
84443 Thyroid stimulating hormone (TSH) <1% 1,081 $26K
80061 Lipid panel <1% 1,705 $26K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 2,688 $23K
84703 <1% 2,077 $20K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 2,484 $20K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 433 $18K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 71 $18K
93971 <1% 271 $16K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 446 $14K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 281 $14K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 428 $12K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 323 $12K
76830 Ultrasound, transvaginal <1% 240 $11K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 791 $11K
84484 <1% 1,393 $10K
81003 <1% 3,460 $10K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 153 $10K
72125 Computed tomography, cervical spine; without contrast material <1% 160 $10K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 829 $10K
77067 Screening mammography, bilateral, including computer-aided detection <1% 104 $9K
83690 <1% 1,927 $9K
83735 <1% 1,466 $9K
71045 Radiologic examination, chest; single view <1% 1,119 $8K
80048 Basic metabolic panel (calcium, ionized) <1% 1,043 $7K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 445 $7K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 322 $7K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 322 $7K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 167 $7K
83036 Hemoglobin; glycosylated (A1C) <1% 907 $7K
96361 Intravenous infusion, hydration; each additional hour <1% 500 $6K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 265 $6K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,853 $6K
85027 <1% 986 $6K
95886 <1% 106 $6K
83880 <1% 219 $6K
73610 <1% 288 $6K
84439 <1% 592 $5K
X0621 <1% 35 $5K
85730 <1% 925 $5K
87086 Culture, bacterial; quantitative colony count, urine <1% 644 $5K
76536 <1% 90 $5K
88342 <1% 115 $5K
83605 <1% 711 $5K
86803 <1% 231 $5K
84702 <1% 278 $5K
86318 <1% 225 $4K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 26 $4K
72100 <1% 219 $4K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 64 $4K
73630 <1% 358 $4K
82607 <1% 321 $4K
87040 <1% 248 $4K
73030 <1% 247 $4K
76801 <1% 85 $4K
70551 Magnetic resonance imaging, brain; without contrast material <1% 14 $4K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 43 $4K
86780 <1% 225 $4K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 15 $4K
85610 <1% 1,153 $4K
82803 <1% 179 $4K
90837 Psychotherapy session, about an hour <1% 72 $3K
36415 Collection of venous blood by venipuncture <1% 12,329 $3K
71250 <1% 54 $3K
76775 <1% 70 $3K
73560 <1% 209 $3K
85378 <1% 318 $3K
73130 <1% 259 $3K
86850 <1% 411 $3K
80076 <1% 310 $3K
86702 <1% 221 $3K
97161 <1% 86 $3K
10060 <1% 25 $2K
86701 <1% 221 $2K
77063 Screening digital breast tomosynthesis, bilateral <1% 81 $2K
87340 <1% 146 $2K
84145 <1% 131 $2K
87390 <1% 221 $2K
82728 <1% 178 $2K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 34 $2K
74018 <1% 165 $2K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 84 $2K
70486 <1% 28 $2K
86901 <1% 471 $2K
86900 <1% 471 $2K
82043 <1% 202 $2K
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml <1% 127 $2K
73110 <1% 133 $1K
93970 <1% 25 $1K
73502 <1% 74 $1K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 44 $1K
87186 <1% 201 $1K
86618 <1% 53 $1K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 29 $1K
95909 <1% 13 $1K
84153 <1% 42 $1K
82550 <1% 153 $1K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 670 $999.90
85651 <1% 331 $990.91
96376 <1% 241 $983.20
90715 <1% 108 $790.72
86762 <1% 37 $773.37
86140 <1% 225 $673.03
74019 <1% 42 $635.29
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,042 $621.25
83550 <1% 111 $557.88
86038 <1% 37 $556.11
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,321 $514.96
82570 <1% 61 $464.40
73080 <1% 38 $450.80
82746 <1% 38 $414.46
82962 <1% 369 $374.42
87077 <1% 54 $326.55
82077 <1% 201 $322.73
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 338 $248.48
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,142 $219.19
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 3,388 $208.90
72040 <1% 14 $199.95
73590 <1% 12 $186.45
82784 <1% 13 $149.08
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 12 $148.42
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 652 $141.27
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 477 $139.48
J2704 Injection, propofol, 10 mg <1% 588 $138.26
76937 <1% 13 $98.40
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 14 $87.57
84100 <1% 15 $85.83
87070 <1% 12 $67.62
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 27 $65.97
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 80 $63.00
J3490 Unclassified drugs <1% 35 $55.05
J3010 Injection, fentanyl citrate, 0.1 mg <1% 586 $52.60
87081 <1% 13 $50.60
83516 <1% 28 $49.60
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 86 $42.91
85018 <1% 15 $40.55
J0690 Injection, cefazolin sodium, 500 mg <1% 188 $38.48
88304 <1% 28 $29.20
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 150 $24.16
J2060 Injection, lorazepam, 2 mg <1% 123 $23.71
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 16 $14.96
J1170 Injection, hydromorphone, up to 4 mg <1% 17 $13.70
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 448 $13.15
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 31 $5.44
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 40 $4.70
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 12 $1.41
3050F 0% 406 $0.00
3051F 0% 12 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 73 $0.00
3044F 0% 577 $0.00
3048F 0% 650 $0.00
3049F 0% 466 $0.00
3011F 0% 1,522 $0.00
G0463 Hospital outpatient clinic visit for assessment and management of a patient 0% 51 $0.00
3061F 0% 42 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialROSENBERGER, ROBERT (CFO)
Same official

Other billing entities under ROSENBERGER, ROBERT

Full network →
ProviderLocationPaid
Adena Health SystemChillicothe, OH$98.12M
Valley Medical Facilities, INC.Sewickley, PA$19.37M
Valley Medical Facilities INCBeaver, PA$10.29M
Valley Medical Facilities, INC.Sewickley, PA$3.71M
Valley Medical Facilities, INC.Mc Kees Rocks, PA$1.86M
Valley Medical Facilities INCMc Kees Rocks, PA$80K
Valley Medical Facilities, INC.Wexford, PA$32K
Valley Medical Facilities, INC.Bellevue, PA$1K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.